June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Optic nerve head basal blood flow increases early and then progressively decreases in non-human primate experimental glaucoma
Author Affiliations & Notes
  • Grant Cull
    Devers Eye Institute, Legacy Research Institute, Portland, OR
  • Chelsea Piper
    Devers Eye Institute, Legacy Research Institute, Portland, OR
  • Claude Burgoyne
    Devers Eye Institute, Legacy Research Institute, Portland, OR
  • Lin Wang
    Devers Eye Institute, Legacy Research Institute, Portland, OR
  • Footnotes
    Commercial Relationships Grant Cull, None; Chelsea Piper, None; Claude Burgoyne, Heidelberg Engineering (F), Heidelberg Engineering (C); Lin Wang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4465. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Grant Cull, Chelsea Piper, Claude Burgoyne, Lin Wang; Optic nerve head basal blood flow increases early and then progressively decreases in non-human primate experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4465.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To study the effect of chronic elevated IOP on optic nerve head (ONH) basal blood flow (bBF) in Non-human Primate (NHP) experimental glaucoma (EG) at progessive stages of retinal nerve fiber layer thickness (RNFLT) loss.

 
Methods
 

In six adult NHPs, two needles were inserted into the anterior chamber of each eye: one connected to a saline reservoir to set the IOP at 10 mmHg; the other recording the actual IOP. Three or more baseline (BL) ONH bBF measurements (excluding large vessels), in units of mean blur rate (MBR) and RNFLT were measured by Laser Speckle Flowgraphy and Spectral Domain Optical Coherence Tomography, respectively. Chronic IOP elevation in the EG eye was induced by laser treatment of the trabecular meshwork with the contralateral eye serving as control (CTL). Bi-weekly ONH bBF and RNFLT measurements were obtained throughout the follow-up period. NHPs were sacrificed when EG eye RNFLT was 40 - 62% thinner than BL. ONH bBF measurements for both eyes were split in 4 groups based on RNFLT loss in the treatment eye: 1) BL (before laser treatment), 2) RNFLT loss <10%, 3) RNFLT loss between 10% and 40%, and 4) RNFLT loss >40. A repeated measure ANOVA and post hoc LSD test assessed EG vs CTL eye ONH bBF change within and between groups.

 
Results
 

Mean (±SD) post-laser IOP was 13.5 ± 2.7mmHg in the CTL eyes and 32 ± 3.8mmHg in the EG eyes During the early stage of EG (RNFLT loss <10%), ONH bBF was significantly increased compared with its BL value (p=0.01 *). As RNFLT decreased further (10-40%), bBF returned to being statistically insignificant from BL (p=0.6). Significant ONH bBF reduction developed (p<0.0001*) once the RNFLT loss was greater than 40%. There was no significant bBF change in the CTL eyes at any stage compared with BL (Fig.1). There was a significant interaction between stage of RNFLT and eyes (p<0.0001).

 
Conclusions
 

ONH bBF increases early and then progressively decreases in NHP EG. The early ONH bBF increase may be the result of autoregulation-induced vasodilation that is a response to the challenges of IOP elevation or may itself be evidence for autoregulation dysfunction. Later ONH bBF decreases is likely the result of reduced metabolic demand or autoregulatory capability.

 
 
Figure 1 shows ONH bBF (MBR) for the EG and CTL eyes in the 6 NHP at progressive stages of RNFLT loss compared with BL.
 
Figure 1 shows ONH bBF (MBR) for the EG and CTL eyes in the 6 NHP at progressive stages of RNFLT loss compared with BL.
 
Keywords: 629 optic nerve • 436 blood supply • 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×